$500 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 53 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 131.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | $65,033,000 | -28.8% | 2,628,678 | 0.0% | 13.01% | -29.2% | |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $42,833,000 | – | 700,000 | +100.0% | 8.57% | – |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $41,026,000 | -8.2% | 9,607,934 | 0.0% | 8.21% | -8.7% | |
| ITOS | ITEOS THERAPEUTICS INC | $30,169,000 | -30.9% | 937,500 | 0.0% | 6.04% | -31.3% | |
| BIO | New | BIO RAD LABS INCcl a | $22,529,000 | – | 40,000 | +100.0% | 4.51% | – |
| HRTX | Sell | HERON THERAPEUTICS INC | $21,278,000 | -70.1% | 3,720,000 | -52.2% | 4.26% | -70.2% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $20,077,000 | -63.7% | 1,265,900 | -50.0% | 4.02% | -63.9% |
| ALT | Buy | ALTIMMUNE INC | $15,674,000 | +6.9% | 2,573,744 | +60.9% | 3.14% | +6.4% |
| GLPG | New | GALAPAGOS NVspon adr | $15,505,000 | – | 250,000 | +100.0% | 3.10% | – |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $14,595,000 | – | 300,000 | +100.0% | 2.92% | – |
| ALBO | New | ALBIREO PHARMA INC | $13,952,000 | – | 467,702 | +100.0% | 2.79% | – |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $11,529,000 | – | 385,600 | +100.0% | 2.31% | – |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $9,683,000 | -6.7% | 750,000 | +15.4% | 1.94% | -7.1% |
| SRRA | New | SIERRA ONCOLOGY INC | $9,615,000 | – | 300,000 | +100.0% | 1.92% | – |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $9,555,000 | – | 648,269 | +100.0% | 1.91% | – |
| New | INSPIRATO INCORPORATED | $8,502,000 | – | 855,368 | +100.0% | 1.70% | – | |
| TCRR | New | TCR2 THERAPEUTICS INC | $8,280,000 | – | 3,000,000 | +100.0% | 1.66% | – |
| ALLK | ALLAKOS INC | $7,543,000 | -41.8% | 1,323,393 | 0.0% | 1.51% | -42.1% | |
| BLUE | New | BLUEBIRD BIO INC | $7,518,000 | – | 1,550,000 | +100.0% | 1.50% | – |
| IONS | New | IONIS PHARMACEUTICALS INC | $7,408,000 | – | 200,000 | +100.0% | 1.48% | – |
| IMGN | IMMUNOGEN INC | $7,140,000 | -35.8% | 1,500,000 | 0.0% | 1.43% | -36.2% | |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $7,118,000 | – | 100,000 | +100.0% | 1.42% | – |
| BNTX | New | BIONTECH SEsponsored ads | $6,822,000 | – | 40,000 | +100.0% | 1.36% | – |
| RCUS | New | ARCUS BIOSCIENCES INC | $6,312,000 | – | 200,000 | +100.0% | 1.26% | – |
| LIFE | ATYR PHARMA INC | $5,957,000 | -28.4% | 1,113,453 | 0.0% | 1.19% | -28.8% | |
| BCAB | Buy | BIOATLA INC | $5,500,000 | -6.0% | 1,100,000 | +269.2% | 1.10% | -6.5% |
| New | 2SEVENTY BIO INC | $5,118,000 | – | 300,000 | +100.0% | 1.02% | – | |
| CRVS | CORVUS PHARMACEUTICALS INC | $5,087,000 | -31.9% | 3,101,709 | 0.0% | 1.02% | -32.3% | |
| TARS | New | TARSUS PHARMACEUTICALS INC | $5,046,000 | – | 300,000 | +100.0% | 1.01% | – |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $4,970,000 | – | 500,000 | +100.0% | 0.99% | – |
| GNFT | Buy | GENFIT S Aads | $4,685,000 | -11.3% | 1,171,361 | +10.9% | 0.94% | -11.8% |
| BLU | Sell | BELLUS HEALTH INC NEW | $4,128,000 | -57.3% | 600,000 | -50.0% | 0.83% | -57.5% |
| VINC | VINCERX PHARMA INC | $4,123,000 | -60.7% | 1,030,634 | 0.0% | 0.82% | -60.9% | |
| New | BRC INC*w exp 02/09/2027 | $3,602,000 | – | 805,900 | +100.0% | 0.72% | – | |
| TANGO THERAPEUTICS INC | $3,553,000 | -30.7% | 468,750 | 0.0% | 0.71% | -31.0% | ||
| FBIO | New | FORTRESS BIOTECH INC | $3,196,000 | – | 2,350,000 | +100.0% | 0.64% | – |
| ASLN | Buy | ASLAN PHARMACEUTICALS LTDads | $2,957,000 | +28.5% | 3,286,122 | +59.9% | 0.59% | +27.9% |
| RVPH | REVIVA PHARMACEUTCLS HLDGS I | $2,952,000 | -14.9% | 1,200,000 | 0.0% | 0.59% | -15.2% | |
| New | NEKTAR THERAPEUTICScall | $2,908,000 | – | 539,600 | +100.0% | 0.58% | – | |
| New | NEKTAR THERAPEUTICSput | $2,908,000 | – | 539,600 | +100.0% | 0.58% | – | |
| VNDA | New | VANDA PHARMACEUTICALS INC | $2,903,000 | – | 256,696 | +100.0% | 0.58% | – |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $2,811,000 | -79.7% | 100,000 | -66.7% | 0.56% | -79.8% |
| New | INSPIRATO INCORPORATED*w exp 02/11/2027 | $2,716,000 | – | 1,400,000 | +100.0% | 0.54% | – | |
| NKTR | New | NEKTAR THERAPEUTICS | $2,318,000 | – | 430,037 | +100.0% | 0.46% | – |
| NKTX | New | NKARTA INC | $2,276,000 | – | 200,000 | +100.0% | 0.46% | – |
| LPTX | Sell | LEAP THERAPEUTICS INC | $2,188,000 | -73.0% | 1,250,000 | -50.0% | 0.44% | -73.1% |
| EQ | EQUILLIUM INC | $1,890,000 | -16.4% | 600,000 | 0.0% | 0.38% | -16.9% | |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $1,817,000 | -80.5% | 50,000 | -75.0% | 0.36% | -80.6% |
| ALEC | New | ALECTOR INC | $1,425,000 | – | 100,000 | +100.0% | 0.28% | – |
| New | TRITIUM DCFC LIMITEDordinary shares | $1,247,000 | – | 124,186 | +100.0% | 0.25% | – | |
| New | SKY HARBOUR GROUP CORPORATIO*w exp 01/23/2027 | $694,000 | – | 459,611 | +100.0% | 0.14% | – | |
| FIXX | New | HOMOLOGY MEDICINES INC | $653,000 | – | 214,898 | +100.0% | 0.13% | – |
| New | TSCAN THERAPEUTICS INC | $560,000 | – | 200,000 | +100.0% | 0.11% | – | |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -152,345 | -100.0% | -0.13% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -59,122 | -100.0% | -0.27% | – |
| CALT | Exit | CALLIDITAS THERAPEUTICS ABsponsored adr | $0 | – | -100,000 | -100.0% | -0.50% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -763,888 | -100.0% | -1.06% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -20,000 | -100.0% | -1.09% | – |
| ODT | Exit | ODONATE THERAPEUTICS INC | $0 | – | -12,767,435 | -100.0% | -3.47% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -500,000 | -100.0% | -3.66% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
| COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
| EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
| RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
| MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-06-01 |
| 4 | 2023-06-01 |
| 4 | 2023-05-30 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.